Inflammasome-mediated IL-18 production has previously been shown to have an essential role in intestinal epithelial barrier function during acute colitis; the enhanced susceptibility to colitis in caspase-1−/−, ASC−/−, and NLRP3−/− mice could be reversed by the administration of IL-18 (15, 17). This evidence concerns the gene CASP1 and colitis.